# Otto Bock Healthcare Products GmbH

- Location (FDA's records): Vienna, AT
- FDA decisions: 3 (2015–2026): 3 510(k) clearances
- Product codes: GXY (2), GZI (1)
- Predicates its devices cite: 6 (1 its own); citations of its devices by later devices: 2 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Infinite Biomedical Technologies, LLC: 2 (https://510kreport.com/company/infinite-biomedical-technologies)
- Innovative Neurotronics, Inc.: 1 (https://510kreport.com/company/innovative-neurotronics)
- Empi: 1 (https://510kreport.com/company/empi)
- Bioness, Inc.: 1 (https://510kreport.com/company/bioness)

## Firms that cite its devices most
- Guangzhou Longest Science & Technology Co., Ltd.: 1 (https://510kreport.com/company/guangzhou-longest-science-technology)

## Its most-cited devices
- K191179: Myo Plus (2019), cited by 1
- K141812: Mygait Stimulation System (2015), cited by 1

## Recent decisions
- K253256: myosmart. (13E522); myosmart.cuff (757M20-2); connectgrip. (560X27-1); myosmart trial kit (642V64=T) (Apr 22, 2026)
- K191179: Myo Plus (Sep 4, 2019)
- K141812: Mygait Stimulation System (Apr 2, 2015)

Source page: https://510kreport.com/company/otto-bock-healthcare-products